Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
JAMA Oncology|July 17, 2015
Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC TrialNiki Karachaliou, Clara Mayo-de las Casas, Cristina Queralt, et al.
Blood Advances|December 7, 2020
Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trialMeletios Dimopoulos, Ramon Garcia Sanz, Hui-Peng Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2023
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN StudyMeletios A Dimopoulos, Stephen Opat, Shirley D'Sa, et al.
Annals of Hematology|July 2, 2022
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patientsJosé Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, et al.
Blood Advances|August 23, 2021
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disordersJames Peter Stewart, Jana Gazdova, Nikos Darzentas, et al.
Science Advances|January 19, 2022
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphomaSara Rodriguez, Jon Celay, Ibai Goicoechea, et al.
Pageof 13